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Ultraviolet radiation (UVR) is associated with an increased risk of squamous cell carcinoma (SCC), which is in part
due to immunomodulation. In addition, human papilloma virus (HPV), especially the epidermodysplasia verruci-
formis (EV)-associated types, may be involved. In view of the capacity of UVR to impair host resistance to
infections, we investigated the relationship between solar exposure and the prevalence of cutaneous HPV. In a
case-control study on skin cancer (320 controls and 156 patients) a lifetime-retrospective questionnaire on sun
exposure was administered. The presence of DNA of HPV types 5, 8, 15, 20, 24, and 38 in plucked eyebrow hair
and type-speciﬁc seroreactivity were assessed and analyzed in relation to estimated exposure. Sunburn
episodes in the past, especially at age 13–20 y, appeared to be associated with an enhanced risk of EV–HPV
DNA positivity. In contrast, a higher lifetime sun exposure was associated with a lower risk of HPV infection. These
results indicate that UVR at erythematogenic doses increases the risk of EV–HPV infection, possibly due to
impaired host resistance to HPV and/or a direct effect of UVR on viral replication. The favorable association
between lifetime sun exposure and HPV prevalence, however, underscores the enigmatic role of HPV in skin
carcinogenesis.
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Human papillomaviruses (HPVs) are associated with both
benign and malignant proliferative skin disorders (Boxman
et al, 2000, 2001; Zur Hausen, 2000; Feltkamp et al, 2003;
Struijk et al, 2003). A quarter of the HPV genotypes that are
completely sequenced today belong to the so-called
epidermodysplasia verruciformis (EV)-associated HPV
types (De Villiers, 2001). These EV–HPV types have
originally been found in skin lesions from patients with EV
(Jablonska and Orth, 1985). EV patients develop multiple
skin lesions on sun-exposed sites that often progress into
squamous cell carcinoma (SCC). Recent studies indicate
that EV–HPV types are not restricted to EV patients. Skin
carcinomas in patients from the general population fre-
quently contain EV–HPV (Pfister and Ter Schegget, 1997;
Harwood and Proby, 2002). In immunosuppressed patients,
such as renal transplant recipients, high incidences of skin
carcinomas and keratotic skin lesions are found on sun-
exposed sites in conjunction with a high percentage of EV–
HPV DNA positivity, suggesting that these phenomena are
associated with an underlying impairment of the immune
system and may be causally linked with each other (Bouwes
Bavinck et al, 1993; Shamanin et al, 1994; De Jong-Tieben
et al, 1995; Berkhout et al, 2000).
It is known that exposure to solar ultraviolet radiation
(UVR) plays a pivotal role in the genesis of pre-malignant
skin lesions and non-melanoma skin cancer. A higher
lifetime-cumulative sun exposure is an important risk factor,
especially for the induction of SCC (Bouwes Bavinck et al,
1993; Kennedy et al, 2003). UVR appears to exert its
carcinogenic effects by both mutagenic and immunomo-
dulatory mechanisms. In the study by Fisher and Kripke, for
example, it was found that pre-exposure of mice to UVR
prevented the rejection of transplanted antigenic skin tumor
cells (Fisher and Kripke, 1977; Kripke, 1982). UVR exposure
resulted in the development of antigen-specific suppressor
T cells and, as a consequence, the UVR-induced high
susceptibility to these skin tumor cells was probably long
lasting. In the human study by Yoshikawa et al (1990), it was
found that a comparatively high percentage (92%) of skin
cancer patients showed a suppressed contact hypersensi-
tivity (CHS) response to 1-chloro-2,4-dinitrobenzene, which
was applied epicutaneously, after exposure to UVR. The
immunotoxic effects of UVR may have important conse-
quences for the host resistance to a number of viral,
bacterial, fungal, and parasitic infections. This was demon-
strated in various animal studies (Sleijffers et al, 2002b).
Immunotoxic effects of UVR, both skin associated and non-
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skin associated, both at the site of irradiation and at a
distant (i.e., non-irradiated) skin locus have been demon-
strated in humans as well (Hersey et al, 1983; Cooper et al,
1992; Kelly et al, 1998; Duthie et al, 1999; Sleijffers et al,
2001). But the relevance for the susceptibility to infections in
humans remains a matter of debate (Selgrade et al, 1997).
In view of the capacity of UVR to promote tumor genesis
and impair host resistance to infections, and the high
prevalence of HPV in non-melanoma skin cancer, it is likely
that both UVR and HPV contribute to cutaneous malig-
nancy. HPV may interfere with UVR-induced apoptosis, as
has been described for the EV–HPV type 5 and appeared to
be mediated by a p53-independent abrogation of the pro-
apoptotic functions of Bak proteins (Jackson et al, 2000).
Furthermore, UVR may increase the risk of HPV infection
itself. One possible mechanism may be the direct effect of
UVR on HPV replication, as has been described for HIV in
human skin (Breuer-McHam et al, 2001). UVR responsive-
ness has been described for HPV77, and appears to be
mediated by a p53-dependent stimulation of viral promoter
activity (Purdie et al, 1999). In addition, enhanced viral
replication in the epidermis may follow UVR-induced local
or systemic immunosuppression, as has been described
for herpes simplex virus (Taylor et al, 1994; Norval and
El-Ghorr, 1998).
The aim of the study was to investigate the relationship
between exposure to sunlight on the one hand and the
presence of DNA of six EV–HPV types (HPV5, 8, 15, 20, 24,
38) in plucked eyebrow hair and the presence of antibodies
against these HPV types on the other. This was done in the
framework of an epidemiological study on risk factors for
skin cancer. We hypothesized that a higher lifetime-
cumulative sun exposure and sunburn episodes in the past
are associated with a higher prevalence of EV–HPV DNA
and/or a higher EV–HPV seroprevalence. This was exam-
ined for healthy controls and patients with SCC separately.
The presence of SCC may confound the relationship
between UVR exposure and HPV, as it is already known
that SCC is associated with both a higher lifetime sun
exposure and a higher prevalence of HPV.
A positive (i.e., unfavorable) association between sun
exposure and prevalence of HPV, irrespective of the
presence of SCC, would indicate that UVR exposure might
have adverse effects on susceptibility to cutaneous HPV
infections in humans. Furthermore, such an association
between sun exposure and HPV infection would indicate
that UVR might promote skin carcinogenesis through an
infectious route, in addition to the known mutagenic and
immunomodulatory pathways.
Results
Population characteristics (Table I) Characteristics of the
study population are shown for controls and SCC cases
separately in Table I. The mean age of controls was 59.4 y,
which was statistically significantly lower than the mean age
of 65.9 y in SCC patients. The percentage of males and
participants with skin type I or II (‘‘fair skin’’) was statistically
significantly lower in controls than in SCC patients. Lifetime
sun exposure was categorized according to the tertiles of
the exposure distribution in the study population as a whole.
The majority of control subjects fell in the low and
intermediate exposure tertiles, whereas the majority of
SCC patients fell in the intermediate and high tertiles. The
reporting of painful sunburns in different age periods was
more frequent in patients with SCC, especially at young
ages (2–12 y). The majority of participants were infected
with at least one of the EV–HPV types 5, 8, 15, 20, 24, or 38.
Among participants with positivity for at least one EV–HPV
DNA type, infection with multiple EV–HPV types was
observed more frequently in SCC patients than in healthy
controls (60.4% vs 44.8%, po0.05). With the exception of
EV–HPV type 38, the prevalence of EV–HPV DNA positivity
for these types in controls was significantly lower than the
prevalence of positivity for the same type in SCC patients.
The prevalence of anti-HPV antibodies against at least one
of the EV–HPV types was low. The prevalence of seropo-
sitivity was higher in patients with SCC than in control
participants. Statistical significance was reached for HPV
type 8, 24, and 38 seropositivity.
EV–HPV DNA positivity (Table II) A higher age and a
history of SCC were significantly and independently
associated with a higher prevalence of EV–HPV DNA when
evaluated for the study population as a whole (Table II).
Male gender appeared to be borderline significantly
associated with a higher EV–HPV prevalence (p¼0.098).
In addition, lifetime sun exposure was negatively associated
with EV–HPV prevalence. Exposure in the highest 33.3%
category was significantly associated with a lower pre-
valence (OR¼0.41, 95% CI: 0.23–0.74). Lower exposure
categories were associated with a higher prevalence, which
means that an inverse relationship between lifetime sun
exposure and HPV prevalence was found. This inverse
association was not substantially modified after excluding
the history of SCC from the model or when the analyses
were performed for controls and SCC patients separately. A
statistically significant inverse association between HPV
prevalence and lifetime sun exposure was found among
controls (Table II). Among patients with SCC, an inverse
association was suggested with borderline statistical sig-
nificance (overall test: p¼ 0.092) (Table II).
Contrary to the inverse association between lifetime
sun exposure and the presence of EV–HPV DNA, painful
sunburns appeared to be associated with a higher
prevalence of EV–HPV DNA (Table II). The reporting of
painful sunburns at age 13–19 y appeared to be significantly
associated with a higher HPV prevalence when evaluated
for the study population as a whole (OR¼1.54, p¼0.047).
This association could also be established when restricting
the analysis to control persons (OR¼1.74, p¼ 0.04), but
was less and non-significant among participants with SCC
(OR¼ 1.18, p¼0.68). Adding the reported painful sunburns
by age period to the model did not substantially modify the
found associations between lifetime-cumulative exposure
to sunlight and EV–HPV DNA prevalence. Reporting of
sunburn during the age period 40–59 y was non-signifi-
cantly associated with a higher risk of EV–HPV DNA
positivity (OR¼1.55, 95% CI: 0.76–3.19). As time at risk
during this age period depended on the age at the time of
study entry, and, as a consequence, a fair comparison is
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hampered, findings for the reported sunburns during the
age period 40–59 y were not included in Table II.
The multivariate analyses for the study group as a whole
were performed for the different types of EV–HPV sepa-
rately. A (borderline) significant association with the pre-
sence of SCC was found for HPV-5 (OR¼1.99, p¼0.02),
HPV-15 (OR¼2.08, p¼ 0.03), and HPV-20 (OR¼ 1.58,
p¼0.055). A significant association between the reporting
of sunburn at age 13–19 y and HPV–DNA positivity was
found for HPV-5 (OR¼1.88, p¼0.02) and HPV-15
(OR¼ 1.81, p¼0.06). No significant associations between
sunburn at age 13–19 y and the other HPV types (HPV-8,
HPV-20, HPV-24, HPV-38) could be established. With
respect to the association with lifetime sun exposure, no
single type stood out. Inverse associations with HPV-5, HPV-
8, HPV-15, HPV-20, and HPV-38 were suggested, but did not
reach the level of statistical significance (data not shown).
EV–HPV seropositivity (Table III) In 14.2% of the parti-
cipants with EV–HPV DNA positivity for any of the
above-mentioned types, EV–HPV seropositivity could be
established. This percentage was not different from
the percentage EV–HPV seropositivity in participants who
were EV–HPV DNA negative for these types (15.8%,
p¼0.64). When these correlations were calculated for the
different EV–HPV types separately, significant correlations
between EV–HPV DNA positivity and EV–HPV seropositivity
could not be established either.
Fair skin type (I/II) was independently correlated with a
higher EV–HPV seroprevalence (OR¼2.10, p¼0.01). This
correlation was found especially among patients with SCC
(OR¼ 3.45, p¼0.02). In patients with SCC, higher age and
male gender were also borderline significantly associated
with a higher EV–HPV seroprevalence (Table III). No
significant association between lifetime sun exposure and
EV–HPV seroprevalence could be established, either in the
study group as a whole or in controls and participants with a
history of SCC separately (Table III). No association was
found when a history of SCC was excluded from the model
for the study group as a whole. Furthermore, no significant
associations between the reported sunburns by age period
and EV–HPV seropositivity could be established. A border-
line significantly higher EV–HPV seropositivity was found in
participants with SCC who reported one or more painful
sunburns during the age period 20–39 y (OR¼ 2.31,
p¼0.056). Because of the small numbers, the analyses
on EV–HPV seropositivity were not performed for the
different EV–HPV types separately.
Discussion
In view of the known relationship between lifetime sun
exposure and sunburns in the past and the occurrence of
non-melanoma skin cancer, especially SCC, on the one
hand, and the involvement of HPV in non-melanoma skin
cancer on the other, we investigated whether parallel
associations between solar exposure and current HPV
infection (DNA positivity) or past HPV infection (presence of
anti-HPV antibodies) might be established. Painful sunburns
in the past, especially at age 13–19 y, appeared to be
associated with an enhanced prevalence of EV–HPV DNA.
This finding agrees with our hypothesis of a higher
susceptibility to viral skin infections following exposure to
solar UVR. Unexpectedly, a statistically significant inverse
Table I. Characteristics of study population according to the
presence of SCC
Controls N¼320
Patients with
history of
SCC N¼ 156
Age
Mean (SD) 59.4 (10.7) 65.9 (8.4)
5%–95% percentiles 41.2–74.7 48.4–76.2
Gender (N and %)
Female 184 (57.5) 56 (35.9)
Male 136 (42.5) 100 (64.1)
Skin type (N and %)
III/ IV 173 (54.1) 53 (34.0)

I/II 147 (45.9) 103 (66.0)
EV–HPV DNA positivity (N and %)
Any type
(5, 8, 15, 20, 24, or 38)
174 (54.4) 111 (71.2)
Type 5 38 (11.9) 37 (23.7)
Type 8 32 (10.0) 27 (17.4)
Type 15 26 (8.1) 26 (16.8)
Type 20 73 (22.8) 51 (32.7)
Type 24 49 (15.3) 39 (25.0)
Type 38 81 (25.3) 50 (32.3)
EV–HPV seropositivity (N and %)
Any type
(5, 8, 15, 20, 24, or 38)
39 (12.5) 30 (19.9)
Type 5 1 (0.3) 2 (1.3)
Type 8 1 (0.3) 5 (3.2)
Type 15 7 (2.2) 6 (3.9)
Type 20 7 (2.2) 7 (4.5)
Type 24 22 (6.9) 20 (12.8)
Type 38 7 (2.2) 9 (5.8)
Lifetime sun exposure (N and %)
o26,642 h 124 (38.8) 31 (19.9),a
26,642–37,734 h 122 (35.0) 49 (31.4)
437,734 h 84 (26.2) 76 (48.7)
Painful sunburns at different age periods (N and %)
Age 2–5 y 10 (3.1) 11 (7.3)
6–12 y 54 (14.1) 39 (25.3)
13–19 y 94 (29.4) 52 (33.6)
20–39 y 97 (30.3) 55 (35.5)
po0.0001; po0.01; Po0.05.
aOne overall test procedure with w2 test for categorized data (df¼ 2).
SCC, squamous cell carcinoma; SD, standard deviation; EV, epider-
modysplasia verruciformis; HPV, human papilloma virus.
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association between lifetime sun exposure and EV–HPV
DNA positivity was found in this analysis. No significant
and consistent association between sunlight exposure and
EV–HPV seropositivity could be established.
In this study, sunlight exposure and number of sunburns
were assessed on the basis of self-reported information,
which has probably introduced inaccuracy. Skin cancer pa-
tients may remember their exposure histories differently
from healthy controls. But we analyzed the relationships
between exposure and HPV infection for SCC cases and
controls separately. In addition, consciousness of being
HPV infected or not is unlikely, which makes that ‘‘informa-
tion bias’’ is probably not relevant to our results. For this
study, it may be argued that the inaccuracy of remembered
sun exposure histories may have introduced a non-
systematic error, which mostly results in attenuation of the
observed associations.
Various human studies indicate that acute erythema-
genic doses of UVR may adversely influence immune
responses that follow the first contact with an antigen,
either at the site of irradiation or at a distant non-irradiated
skin site (Cooper et al, 1992; Duthie et al, 1999; Kelly et al,
2000; Termorshuizen et al, 2002). In addition, induction of
antigen-specific tolerance following erythemagenic doses
of UVR was demonstrated in humans (Cooper et al, 1992).
In view of the found association between the immunosup-
pressive/-tolerogenic and erythemagenic effects of UVR in
humans, we may argue that sunburn experienced shortly
prior to or at the time of first infection with an HPV type may
impair the host resistance to that virus (and probably also
other viral infections) and result in a higher HPV prevalence
in adulthood.
UVR may alter certain immune functions in humans at
sub-erythemal doses as well (Gilmour et al, 1993; Kelly et al,
2000). The possible subtle effect of UVR at sub-erythemal
doses on host resistance to infections in humans, however,
may be overruled by many other factors associated with
outdoor behavior. As a consequence, this effect may be
difficult to establish in retrospective epidemiological stu-
dies, especially in those of a restricted nature in terms of
size, exposure assessment, and adjustments for confound-
ing variables (Termorshuizen et al, 2002).
Although epidemiological and experimental studies over-
whelmingly implicate HPV as an important causal agent in
cervical cancer, the causal link between HPV and skin
carcinogenesis remains a matter of debate (Harwood and
Proby, 2002). We cannot exclude the possibility that HPV
is just ‘‘hitching a ride’’ (De Gruijl, 2002), and has no
carcinogenic properties in itself. We found a high preva-
lence of EV–HPV DNA in healthy controls (54%), which
indicates that HPV is ubiquitous. In the study of Antonsson
et al (2000), HPV DNA was detected in at least one of the
samples from five different body sites from 64 of 80 healthy
humans (80%). Most of the HPV types detected in this
study belonged to the EV-associated HPVs. In the same
study (Antonsson et al, 2000), HPV prevalence was found to
be higher on the forehead compared with other (UVR non-
exposed) body sites. This suggests a role for UVR-induced
local immunosuppression. Our data did not allow an
analysis of HPV prevalence by different skin sites. Still, the
Table II. Association between lifetime sun exposure, episodes of painful sunburn, and the prevalence of EV–HPV DNA
(type 5, 8, 15, 20, 24, or 38)
Controls and SCC patients (n¼476) Controls only (n¼320) SCC patients (n¼156)
OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
Multivariate model
Age (1 y increase) 1.03 1.01–1.05 0.009 1.04 1.01–1.06 0.01 1.01 0.96–1.06 0.63
Gender (ref.¼ female) 1.40 0.94–2.08 0.098 1.50 0.94–2.40 0.092 1.16 0.54–2.49 0.70
Skin type I/II (ref.¼ III/IV) 0.97 0.66–1.42 0.86 1.04 0.66–1.64 0.87 0.89 0.41–1.91 0.76
Presence of SCC (ref.¼no) 1.96 1.25–3.07 0.003 – – – –
Lifetime sun exposure
437,734 h 0.41 0.23–0.74 0.013a 0.45 0.22–0.92 0.057a 0.42 0.14–1.27 0.092a
26,642–37,734 h 0.63 0.37–1.06 0.54 0.30–0.98 1.00 0.31–3.26
o26,642 h (¼ ref.) 1.00 – 1.00 – 1.00 –
Painful sunburns at different age periods
2–5 y (ref.¼no) 1.63 0.60–4.44 0.34 1.96 0.48–7.98 0.35 1.31 0.31–5.48 0.71
6–12 y (ref.¼ no) 1.08 0.64–1.82 0.78 1.68 0.83–3.38 0.15 0.54 0.24–1.22 0.14
13–19 y (ref.¼no) 1.54 1.01–2.37 0.047 1.74 1.04–2.91 0.04 1.18 0.54–2.60 0.68
20–39 y (ref.¼no) 1.13 0.75–1.71 0.57 1.04 0.63–1.72 0.88 1.39 0.65–2.98 0.40
aOne overall test procedure with Wald w2 (df¼ 2).
EV, epidermodysplasia verruciformis; HPV, human papilloma virus; SCC, squamous cell carcinoma; OR, odds ratio; CI, confidence interval.
Note: Bold indicates statistical difference (po0.05) as established either by 95%-C1 or by overall p value. Non Bold: non-significance (p40.10) or
borderline significance (p value in range of 0.05–0.10).
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inverse association between lifetime-cumulative solar ex-
posure and the prevalence of skin EV–HPV DNA throws
doubt on the hypothetical causal role of these viruses in
UVR-associated skin carcinogenesis.
The concomitantly positive (i.e., unfavorable) association
with sunburn, however, indicates that the relationship
between sunlight and human health is not one-dimensional
and that exposure to sunlight may be associated with both
favorable and adverse health consequences. Opposite
associations between sun exposure and sunburn on the
one hand and health outcome on the other have been
described for cutaneous melanoma in adults (Kaskel et al,
2001; Kennedy et al, 2003) and respiratory tract symptoms
in young children (Termorshuizen et al, 2002). Whether the
favorable association between lifetime sun exposure and
HPV infection is related to melanogenesis and increased
thickness of the epidermis, a diminished exposure to micro-
organisms, or to the reported anti-proliferative and immu-
nological effects of vitamin D remains to be established
(Manolagas et al, 1985; De Gruijl, 1997; Kaskel et al, 2001).
The idea that ‘‘light’’ or UVR may have a beneficial effect on
immunity and infections in humans has a long history
(Finsen, 1901; Barenberg et al, 1926; De Gruijl, 1997);
however, further mechanistic studies, preferentially in hu-
man volunteers, are required to establish evidence for a
possible favorable influence of sunlight, probably UVR over
a certain range of low doses, on immunity and related
infections.
The finding of a positive association between sunburn
and HPV–DNA positivity may also be due to keratinocyte
proliferation and associated activation of the HPV life cycle.
In the study of Favre et al (2000), it was found that second-
degree burns were associated with a short-term and
probably transient generation of anti-HPV5 antibodies.
Extensive re-epithelialization may account for the higher
susceptibility to HPV infection or to a higher expression of
HPV after a latently established infection, which may
enhance the ability of HPV to induce humoral immune
responses (Favre et al, 1998).
We could not establish significant associations between
HPV seropositivity and sunlight exposure or sunburn. This
may be explained by the fact that both estimates of UVR
exposure relate to exposure in the past and antibodies to
HPV develop transitionally, or probably often do not develop
at all after HPV infection.
The discrepancy between virological and serological
data indicates that current HPV infection and the presence
of anti-HPV antibodies show no important association. In
addition, suppressive effects of UVR on humoral immunity,
both Th-1 and Th-2 associated, have been described,
which further complicates interpretation of the results
(Garssen et al, 1999; Sleijffers et al, 2002a). Erythemal
doses of UVR may promote local HPV skin infection and, as
a consequence, enhance the ability of HPV to induce
humoral immune responses. On the other hand, UVR may
concomitantly suppress serological responses. These pos-
sible opposite effects on serology associated with UVR
exposure are probably hard to disentangle, especially in the
observational design of this study.
In conclusion, the presented epidemiological data indicate
that at sub-erythemal UVR doses no adverse effects on HPV
infection can be detected. The higher occurrence of HPV
Table III. Association between lifetime sun exposure, episodes of painful sunburn, and the serorecognition of EV–HPV
(type 5, 8, 15, 20, 24, or 38)
Controls and SCC patients (n¼464) Controls only (n¼313) SCC patients (n¼151)
OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
Multivariate model
Age (1 y increase) 1.02 0.99–1.05 0.27 1.00 0.96–1.04 0.91 1.06 0.99–1.12 0.08
Gender (ref.¼ female) 1.58 0.91–2.76 0.11 1.14 0.56–2.32 0.71 2.61 0.95–7.14 0.06
Skin type I/II (ref.¼ III/IV) 2.10 1.18–3.65 0.01 1.68 0.84–3.36 0.14 3.45 1.18–10.0 0.02
Presence of SCC (ref.¼no) 1.25 0.70–2.22 0.45 – – – –
Lifetime sun exposure
437,734 h 0.95 0.44–2.06 0.99a 1.45 0.50–4.16 0.77a 0.65 0.20–2.14 0.70a
26,642–37,734 h 0.95 0.46–1.96 1.10 0.44–2.73 0.91 0.26–3.24
o26,642 h (¼ ref.) 1.00 – 1.00 – 1.00 –
Painful sunburns at different age periods
2–5 y (ref.¼no) 0.92 0.25–3.36 0.90 0.69 0.10–5.76 0.73 1.21 0.21–6.92 0.83
6–12 y (ref.¼ no) 1.41 0.75–2.65 0.29 1.18 0.46–3.01 0.73 2.06 0.81–5.24 0.13
13–19 y (ref.¼no) 0.68 0.37–1.23 0.20 0.63 0.28–1.41 0.26 0.75 0.30–1.89 0.54
20–39 y (ref.¼no) 1.29 0.75–2.23 0.36 0.80 0.37–1.73 0.58 2.31 0.98–5.44 0.056
aOne overall test procedure with Wald w2 (df¼ 2).
EV, epidermodysplasia verruciformis; HPV, human papilloma virus; SCC, squamous cell carcinoma; OR, odds ratio; CI, confidence interval.
Note: Bold indicates statistical difference (po0.05) as established either by 95%-C1 or by overall p value. Non Bold: non-significance (p40.10) or
borderline significance (p value in range of 0.05–0.10).
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DNA found in association with sunburn is in accordance with
other recent human studies that indicate adverse effects of
UVR on immunity, infections, and skin tumor genesis, at least
at doses that cause erythema. As no unequivocal relation-
ships between solar exposure in the past and HPV infection
could be established, the involvement of HPV in UVR-
associated skin cancer remains enigmatic.
Materials and Methods
Study population This study was embedded in the ‘‘Leiden Skin
Cancer Study’’ (LSS) that was initiated at the Leiden University
Medical Center (LUMC) in 1997 as a case–control study on the
causes of skin cancer in the Dutch population. The medical ethical
committee approved the protocol, and all participants gave
informed consent. The design of this study was described earlier
(De Hertog et al, 2001). In short, 580 newly diagnosed cases from
1985 till 1997 with histologically confirmed skin cancer were
studied; 161 persons out of these cases were diagnosed with SCC.
Controls (N¼ 386) were recruited at the ophthalmology outpatient
clinic. Controls were excluded when they had an intra-ocular
melanoma or skin cancer in their history. Furthermore, both cases
and controls were excluded when they were transplant recipients
or suffered from hereditary skin disorders with an increased risk of
skin cancer. Dark skinned persons (Fitzpatrick skin type classifi-
cationXV) were also excluded, since they very rarely develop skin
cancers. For this study, we selected persons for whom the
(sero)prevalence of EV–HPV types 5, 8, 15, 20, 24, 38 in serum
and in plucked hair was assessed, respectively (Feltkamp et al,
2003; Struijk et al, 2003). Three hundred and twenty controls and
156 patients with SCC were eligible for this analysis.
Data collection Participants were sent an invitation for a visit at
the Dermatology outpatient clinic. Along with this invitation, a
so-called Residence Work Calendar was sent. In this form, every
change in residence or working environment during the lifetime had
to be marked, and this was done to facilitate the assessment of
sun exposure in the past during the interview at the outpatient
clinic. The visit at the Dermatology outpatient clinic consisted of
a standardized interview and a physical examination. Information
on the propensity to burn rather than tan (skin type) and type
and duration of sun exposure was collected during the interview
using a standardized questionnaire (which can be obtained from
Dr Bouwes Bavinck). Hours spent outdoors were recorded for
working and non-working days between 09:00 and 16:00 hours in
the months May–September. The whole year was taken into
account when people had lived near the equator. Sunburns were
asked for by different age periods that corresponded with infancy
(2–5 y), primary school (6–12 y), secondary school (13–19 y), and
adulthood (20–39 y).
Assessment of EV–HPV DNA in plucked hair DNA was isolated
from 8–10 plucked eyebrow hairs collected per patient, as
described (Boxman et al, 2000). Within each preparation, EV–
HPV DNA was detected by specific PCR for EV–HPV types 5, 8, 15,
20, 24, and 38 with primers located in the viral E7 gene using
amplitaq Gold DNA polymerase (Applied Biosystems, Branchburg,
NJ), as recently described (Struijk et al, 2003). The DNA quality of
each sample was ascertained by PCR amplification of the
household gene Myb (Boxman et al, 1997).
Assessment of anti-EV–HPV antibodies The detection of EV–
HPV-reactive IgG antibodies in patient sera was performed by
ELISA, as described (Feltkamp et al, 2003). For this purpose, L1
virus-like particles of EV–HPV types 5, 8, 15, 20, 24, and 38 were
expressed, purified, and coated to Polysorp microtiter plates
(Nunc). Patient sera were tested in a 1:100 dilution, and optical
densities were measured and corrected, as described. Calcula-
tions of the EV–HPV type specific ELISA cut-off values above
which a serum is called seropositive were based on the mean
reactivity plus 3  SD of a group of 100 randomly selected
anonymous LUMC employees, excluding outliers.
Statistical analysis Univariate analyses were performed using the
non-parametric one-way Wilcoxon test for continuous data and the
w2 test for categorized data. The presence of EV–HPV DNA and
anti-EV–HPV antibodies in relation to sunlight exposure was also
analyzed in multivariate logistic regression models, in which adjust-
ments were made for age, gender, skin type, and the presence
of SCC. All calculations were performed with SAS statistical soft-
ware, version 8.0 for Windows. The statistical contribution of a
categorized variable with more than two levels was evaluated by
individual odds ratios (ORs) and associated 95% confidence
intervals (CIs) and by one overall-test procedure (Wald w2 test).
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